Immunology, Molecular biology, Hepatitis C virus, Virus and Cell biology are his primary areas of study. His Immunology research is multidisciplinary, incorporating perspectives in Apoptosis and Cancer research. His Molecular biology research is multidisciplinary, relying on both Phosphoprotein, Gene, Transfection, Small nuclear RNA and Splenocyte.
His Virus research is within the category of Virology. His Virology research includes themes of Plasmid, DNA vaccination, Antibody and Heterologous. His biological study spans a wide range of topics, including Cell cycle checkpoint, Cytotoxic T cell, In vitro, Cytokine and In vivo.
His primary areas of study are Immunology, Virology, Immune system, Molecular biology and DNA vaccination. His work is dedicated to discovering how Immunology, Cytotoxic T cell are connected with Cell biology and other disciplines. His work carried out in the field of Virology brings together such families of science as Plasmid, Antibody and Recombinant DNA.
In his study, Mesenchymal stem cell, Cancer immunotherapy and Pathology is strongly linked to Cancer research, which falls under the umbrella field of Immune system. His Molecular biology study combines topics from a wide range of disciplines, such as Long terminal repeat and Fusion protein. His research integrates issues of CD8 and Cytokine in his study of T cell.
Young Chul Sung mainly investigates Internal medicine, Immune system, Cancer research, Cell biology and Pharmacology. His research combines Myeloid and Immune system. The concepts of his Cancer research study are interwoven with issues in Mesenchymal stem cell, Combination therapy, Bone morphogenetic protein 2 and Cancer immunotherapy.
The study incorporates disciplines such as B cell and Genetically modified organism in addition to Cell biology. His study in Pharmacology is interdisciplinary in nature, drawing from both Antibody and Anemia. His CD8 study combines topics in areas such as Vaccination, Virology, Immunization, DNA vaccination and Viral load.
The scientist’s investigation covers issues in Internal medicine, Immune system, Cancer research, Cancer immunotherapy and Granzyme B. All of his Immune system and Immunization and DNA vaccination investigations are sub-components of the entire Immune system study. His Cancer research study integrates concerns from other disciplines, such as Cell culture, Leukocyte proliferation, Natural killer cell, Cytotoxic T cell and Flow cytometry.
His Cancer immunotherapy research includes elements of Immune checkpoint, Innate immune system and Tumor microenvironment. Young Chul Sung combines subjects such as Pharmacokinetics, Pharmacodynamics, Immunogenicity and Immunoglobulin D with his study of Adverse effect. His work deals with themes such as Ex vivo, ELISPOT, Cervical intraepithelial neoplasia and Randomization, which intersect with Clinical endpoint.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
STAT3 and NF-κB Signal Pathway Is Required for IL-23-Mediated IL-17 Production in Spontaneous Arthritis Animal Model IL-1 Receptor Antagonist-Deficient Mice
Mi La Cho;Jung Won Kang;Young Mee Moon;Hyo Jung Nam.
Journal of Immunology (2006)
Local structural elements in the mostly unstructured transcriptional activation domain of human p53.
Hyun Lee;K. Hun Mok;Ranjith Muhandiram;Kyu Hwan Park.
Journal of Biological Chemistry (2000)
Dual roles of human BubR1, a mitotic checkpoint kinase, in the monitoring of chromosomal instability
Hyun Jin Shin;Kwan Hyuck Baek;Ae Hwa Jeon;Moon Taek Park.
Cancer Cell (2003)
Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients
Tae Jin Kim;Hyun-Tak Jin;Soo-Young Hur;Hyun Gul Yang.
Nature Communications (2014)
A novel Bcl-2 related gene, Bfl-1, is overexpressed in stomach cancer and preferentially expressed in bone marrow.
S S Choi;I C Park;J W Yun;Y C Sung.
2.8 A resolution crystal structure of human TRAIL, a cytokine with selective antitumor activity.
Sun-Shin Cha;Min-Sung Kim;Yo Han Choi;Byung-Je Sung.
Hepatitis C Virus Core from Two Different Genotypes Has an Oncogenic Potential but Is Not Sufficient for Transforming Primary Rat Embryo Fibroblasts in Cooperation with the H-ras Oncogene
Jun Chang;Se-Hwan Yang;Young-Gyu Cho;Soon Bong Hwang.
Journal of Virology (1998)
Gene therapy of intracranial glioma using interleukin 12-secreting human umbilical cord blood-derived mesenchymal stem cells.
Chung Heon Ryu;Sang-Hoon Park;Soon A Park;Seong Muk Kim.
Human Gene Therapy (2011)
Transactivation Ability of p53 Transcriptional Activation Domain Is Directly Related to the Binding Affinity to TATA-binding Protein
Jun Chang;Do-Hyung Kim;Seung Woo Lee;Kwan Yong Choi.
Journal of Biological Chemistry (1995)
Cutting Edge: CpG DNA inhibits dendritic cell apoptosis by up-regulating cellular inhibitor of apoptosis proteins through the phosphatidylinositide-3'-OH kinase pathway.
Yunji Park;Seung Woo Lee;Young Chul Sung.
Journal of Immunology (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: